Cargando…
Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ()
INTRODUCTION: There is evidence that supports the association of dense tumor infiltrating lymphocyte (TILs) with an increased risk of ipsilateral recurrence in ductal carcinoma in situ (DCIS). However, the association of cellular composition of DCIS immune microenvironment with the histopathologic p...
Autores principales: | Darvishian, Farbod, Wu, Yinxiang, Ozerdem, Ugur, Chun, Jennifer, Adams, Sylvia, Guth, Amber, Axelrod, Deborah, Shapiro, Richard, Troxel, Andrea B., Schnabel, Freya, Roses, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062471/ https://www.ncbi.nlm.nih.gov/pubmed/35489232 http://dx.doi.org/10.1016/j.breast.2022.04.004 |
Ejemplares similares
-
A case report of COVID‐19 in an asymptomatic patient with newly diagnosed breast cancer
por: Cen, Cindy, et al.
Publicado: (2021) -
Changes in Breast Cancer Presentation during COVID-19: Experience in an Urban Academic Center
por: Diskin, Brian, et al.
Publicado: (2023) -
Clinical Characteristics in Patients with Triple Negative Breast Cancer
por: Yeh, Janet, et al.
Publicado: (2017) -
Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
por: Tamura, Nobuko, et al.
Publicado: (2015) -
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Almekinders, Mathilde M. M., et al.
Publicado: (2021)